Milestone Pharmaceuticals Inc. (MIST) Debt by Year
Milestone Pharmaceuticals Inc. carried $57.2M in long-term debt against $73.0M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 7.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Milestone Pharmaceuticals Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MIST Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
MIST Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $59.2M+7.2% | $58.2M+7.2% | $57.2M+7.2% | $56.2M+7.2% | $55.2M+7.2% | $54.3M+7.2% | $53.4M+7.2% | $52.4M+7.2% | $51.5M+7.2% | $50.6M+7.0% | $49.8M | $48.9M |
| Cash & Equivalents | $169.7M+299.4% | $71.3M+58.2% | $73.0M+188.6% | $46.7M+264.8% | $42.5M+220.5% | $45.1M+345.0% | $25.3M+84.0% | $12.8M+29.6% | $13.3M-59.3% | $10.1M-86.3% | $13.8M+80.2% | $9.9M-73.5% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Milestone Pharmaceuticals Inc. financials
Frequently Asked Questions
What was Milestone Pharmaceuticals Inc.'s long-term debt in fiscal year 2025?
Milestone Pharmaceuticals Inc. carried $57.2M in long-term debt against $73.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Milestone Pharmaceuticals Inc.'s long-term debt growing?
Milestone Pharmaceuticals Inc. (MIST) long-term debt rose by 7.2% year over year, from $53.4M to $57.2M in fiscal year 2025.
What was Milestone Pharmaceuticals Inc.'s long-term debt in the most recent quarter?
Milestone Pharmaceuticals Inc. (MIST) reported $59.2M in long-term debt in Q2 2026. This represents an increase of 7.2% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Milestone Pharmaceuticals Inc. (MIST) reported on that line in every period on record.